BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6833 related articles for article (PubMed ID: 3020255)

  • 1. Indomethacin induces the suppression of plasma neutral proteinase activity in mice: possible relationship to efficacy as an anti-inflammatory drug and induction of alterations in the immune system.
    Hart DA
    J Clin Lab Immunol; 1986 Aug; 20(4):199-205. PubMed ID: 3020255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mice with indomethacin leads to the appearance of a 125,000 dalton plasma protein with the characteristics of an acute phase reactant.
    Hart DA; Mannerfeldt J; Babins E
    J Clin Lab Immunol; 1987 Jun; 23(2):83-90. PubMed ID: 2442392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corynebacterium parvum, but not BCG, induces elevations in plasma proteinase activity similar to those observed in tumor-bearing mice.
    Hart DA
    Haemostasis; 1987; 17(1-2):79-88. PubMed ID: 3297943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc(Min/+)mice.
    Chiu CH; McEntee MF; Whelan J
    Prostaglandins Leukot Essent Fatty Acids; 2000 May; 62(5):269-75. PubMed ID: 10883057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors.
    Cahlin C; Gelin J; Andersson M; Lönnroth C; Lundholm K
    Int J Oncol; 2005 Oct; 27(4):913-23. PubMed ID: 16142306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of peritoneal carcinomatosis recurrence with a prostaglandin synthesis inhibitor, indomethacin].
    Narisawa T; Takahashi M; Masuda T; Nagasawa O; Koyama H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2496-501. PubMed ID: 3476022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc.
    Zhu GH; Wong BC; Eggo MC; Ching CK; Yuen ST; Chan EY; Lai KC; Lam SK
    Br J Cancer; 1999 Feb; 79(3-4):393-400. PubMed ID: 10027304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of NF-kappa B in cancer cachexia].
    Zhou W; Jiang ZW; Jiang J; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
    Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
    Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin and telomerase activity in tumor growth retardation.
    Lönnroth C; Andersson M; Lundholm K
    Int J Oncol; 2001 May; 18(5):929-37. PubMed ID: 11295037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA
    Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium chloride: protective and antisecretory properties in rats.
    Wong RK; Boedeker B; Hickey TM; Wilkinson DS; Johnson LF
    Gastroenterology; 1984 Aug; 87(2):362-71. PubMed ID: 6329891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
    Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
    Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle.
    Brooks G; Yu XM; Wang Y; Crabbe MJ; Shattock MJ; Harper JV
    J Pharm Pharmacol; 2003 Apr; 55(4):519-26. PubMed ID: 12803774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing mice.
    Drake WP; Kopyta LP; Levy CC; Mardiney MR
    Cancer Res; 1975 Feb; 35(2):322-4. PubMed ID: 1053698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effect of different non-steroidal anti-inflammatory drugs on human polymorphonuclear leukocyte activity measured by luminol-dependent chemiluminescence of the whole blood.
    Abdullah AS; Jawad AM; Al-Hashimi AH
    Saudi Med J; 2001 Apr; 22(4):360-5. PubMed ID: 11331497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S; Naruo K; Shiho O; Tsukamoto K
    Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 342.